Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 2,135 | 3,004 | 4,866 | 6,933 |
| Cost of Goods | N/A | 620 | 608 | 1,558 | 1,418 |
| Gross Profit | N/A | 1,515 | 2,396 | 3,308 | 5,515 |
| Operating Expenses | 7,181 | 31,801 | 35,611 | 32,764 | 38,273 |
| Operating Income | -7,181 | -29,666 | -32,607 | -28,898 | -32,340 |
| Other Income | 206 | -1,030 | 270 | 866 | 861 |
| Pre-tax Income | -6,975 | -30,696 | -32,337 | -28,032 | -31,479 |
| Net Income Continuous | -6,975 | -30,696 | -32,337 | -28,032 | -31,479 |
| Net Income | $-6,975 | $-30,696 | $-32,337 | $-28,032 | $-31,479 |
| EPS Basic Total Ops | -2.71 | -20.24 | -21.52 | -18.73 | -20.89 |
| EPS Basic Continuous Ops | -2.71 | -20.24 | -21.37 | -18.62 | -21.00 |
| EPS Diluted Total Ops | -2.71 | -20.24 | -21.52 | -18.73 | -20.89 |
| EPS Diluted Continuous Ops | -2.71 | -20.24 | -21.37 | -18.62 | -21.00 |
| EPS Diluted Before Non-Recurring Items | -13.33 | -20.17 | -21.25 | N/A | N/A |
| EBITDA(a) | $-7,176 | $-29,624 | $-31,912 | $-28,480 | $-31,858 |